Javier García Cogorro, Viralgen CEO
July 1, 2021 08:55 AM EDT
Outsourcing
Manufacturing

A vi­ral vec­tor play­er is ex­pand­ing its foot­print in Basque Coun­try amid height­ened de­mand

Josh Sullivan

As the de­mand for vi­ral vec­tors grows un­abat­ed amid the Covid-19 pan­dem­ic, a CD­MO is drop­ping a se­ri­ous in­vest­ment to build out a new Basque …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

A service from the Financial Times